Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
The Journal of Infectious Diseases
|
September 13, 2012
A(H1N1)pdm09 vaccination of health care workers: improved immune responses in low responders following revaccination
Rishi Delan Pathirana, Geir Bredholt, Per Espen Akselsen, et al.
The Journal of Infectious Diseases
|
January 12, 2013
Reply to Sambhara
Geir Bredholt, Gabriel Kristian Pedersen, Rishi Delan Pathirana, et al.
Systematic Reviews
|
January 10, 2026
Systematic review protocol: evaluation of candidate platforms and vaccines for emerging and re-emerging viral threats
Amit Bansal, Ida Sofie Karlsen Sletten, Tung Thanh Le, et al.
Vaccine
|
June 21, 2014
Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination
Gabriel Kristian Pedersen, Katja Höschler, Sara Marie Øie Solbak, et al.
Vaccine
|
June 27, 2026
A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc trial)
Cristina Prat-Aymerich, Lusine Yeghiazaryan, Rishi Delan Pathirana, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
The Journal of Infectious Diseases
|
September 13, 2012
A(H1N1)pdm09 vaccination of health care workers: improved immune responses in low responders following revaccination
Rishi Delan Pathirana, Geir Bredholt, Per Espen Akselsen, et al.
The Journal of Infectious Diseases
|
January 12, 2013
Reply to Sambhara
Geir Bredholt, Gabriel Kristian Pedersen, Rishi Delan Pathirana, et al.
Systematic Reviews
|
January 10, 2026
Systematic review protocol: evaluation of candidate platforms and vaccines for emerging and re-emerging viral threats
Amit Bansal, Ida Sofie Karlsen Sletten, Tung Thanh Le, et al.
Vaccine
|
June 21, 2014
Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination
Gabriel Kristian Pedersen, Katja Höschler, Sara Marie Øie Solbak, et al.
Vaccine
|
June 27, 2026
A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc trial)
Cristina Prat-Aymerich, Lusine Yeghiazaryan, Rishi Delan Pathirana, et al.
Page
of 1